A Case Report of Adjuvant Molecular Hydrogen Therapy in Refractory Rheumatoid Arthritis With Atlantoaxial Subluxation.

In Vivo · 2025 · PMC12588223 · PMID 41167690

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

In our case, both Fas+ effector CD4+ T helper cells and Fas+ effector CD8+ cytotoxic T cells demonstrated a decreasing trend following molecular hydrogen therapy.

also in 47,180 other papers

an increasing trendno p-value reported

The immunomodulatory effects of hydrogen therapy revealed an increasing trend in the percentage of B regulatory cells (Breg).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.